New drug for tardive dyskinesia:
Correct Answer: Valbenazine
Description: C i.e. ValbenazineRef: https://www. accessdata. fda. gov/drugsatfda_docs/label/2017/209241lbl. pdfExplanation:Valbenazine:Vesicular monoamine transporter 2 (VMAT2) inhibitor.Specifically indicated for the treatment of adults with tardive dyskinesia.Supplied as a capsule for oral administration.Tetrabenazine:Centrally-acting dopamine depletor.Selective and reversible.Used in chorea associated with Huntington's disease.Deutetrabenazine: (Approved in April 2017)It is a vesicular monoamine transporter 2 (VMAT2) inhibitor.Specifically indicated for the treatment of chorea associated with Huntington's disease.Supplied as a tablet for oral administration.Safinamide:MAO B inhibitor.Approved for treatment of on off phenomena seen with levodopa in parkinson's disease.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now